Compare DOLE & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DOLE | OPK |
|---|---|---|
| Founded | 1851 | 2007 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Farming/Seeds/Milling | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.0B |
| IPO Year | 2021 | 1995 |
| Metric | DOLE | OPK |
|---|---|---|
| Price | $15.21 | $1.33 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $2.28 |
| AVG Volume (30 Days) | 951.2K | ★ 3.3M |
| Earning Date | 11-10-2025 | 10-29-2025 |
| Dividend Yield | ★ 2.23% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.15 | N/A |
| Revenue | ★ $8,974,210,000.00 | $642,067,000.00 |
| Revenue This Year | $9.28 | N/A |
| Revenue Next Year | $1.84 | N/A |
| P/E Ratio | $101.68 | ★ N/A |
| Revenue Growth | ★ 7.09 | N/A |
| 52 Week Low | $12.20 | $1.11 |
| 52 Week High | $15.73 | $2.04 |
| Indicator | DOLE | OPK |
|---|---|---|
| Relative Strength Index (RSI) | 62.65 | 47.09 |
| Support Level | $15.32 | $1.30 |
| Resistance Level | $15.65 | $1.42 |
| Average True Range (ATR) | 0.27 | 0.05 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 57.32 | 35.95 |
Dole PLC operates in the North American and European markets for fresh fruits and vegetables. The company's segment includes Fresh Fruit; Diversified Fresh Produce - EMEA; Diversified Fresh Produce - Americas and ROW. It generates maximum revenue from the Diversified Fresh Produce - EMEA segment. Diversified Fresh Produce - EMEA segment includes Dole's Irish, Dutch, Spanish, Portuguese, French, Italian, U.K., Swedish, Danish, South African, Eastern European, and Brazilian businesses, the majority of which sell a variety of imported and local fresh fruits and vegetables through retail, wholesale and, in some instances, food service channels across the European marketplace.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.